Eli Lilly shares fell after the company’s oral drug showed less weight loss than hoped. It could still be huge.

Orforglipron, the new weight loss pill manufactured by Eli Lilly, helped patients in a recent study lose a significant amount ...

By Dennis Thompson HealthDay ReporterFRIDAY, Aug. 8, 2025 (HealthDay News) — More than 1 in 10 Americans have used a GLP-1 ...

In 2024, I found a new primary care doctor, who promised to treat “the whole person.” She, too, urged me to keep losing ...

Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial ...

Forget crash diets and other fads: we spoke to experts for advice on safe, scientific approaches to meeting your weight goals ...

In a Phase 3 trial, drugmaker Eli Lilly and Company said it's oral GLP-1 pill showed similar results to injectable weight ...

Homelessness minister Rushanara Ali has been forced to resign after it was alleged that she "ejected" tenants from one of her ...

Now, new clinical trial results suggest that an oral form of this medication may be coming soon—and the results so far are ...

Weight-loss drugs are expected to pull in more than $150 billion in industry-wide revenue by the early 2030s, thanks to the ...

In the first Phase 3 trial of its once-daily oral GLP-1 pill in people with obesity, drugmaker Eli Lilly said Thursday that ...

The experimental obesity medicine is one of two that could offer alternatives to weight-loss injections within the next year ...